Dunnigan-Kobberling syndrome: An autosomal dominant form of partial lipodystrophy

QJM: An International Journal of Medicine

Volumn 90, Issue 1, 1997, Pages 27-36

  Jackson, S N J ^a,c   Howlett, T A ^a   Mcnally, P G ^a   O'Rahilly, S ^b   Trembath, R C ^a,c  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; SYNDROME;

EID: 0031028991     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.1.27     Document Type: Article

References (32)

1. Dunnigan MG, Cochrane MA, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med 1974; 169:33-48.
2. Kobberling J, Dunnigan MG. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet 1986; 23:120-7.
3. Wettke-Schafer R, Kantner G. X-linked dominant inherited diseases with lethality in hemizygous males. Hum Genet 1983; 64:1-23.
4. Stunkard AJ, Sorensen TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F. Adoption study of human obesity. N Engl J Med 1986; 314:193-8.
5. Poehl ET, Tremblay A, Despres JP, Fontaine E, Perusse L, Theriault G, Bouchard C. Genotype-controlled changes in body composition and fat morphology following overfeeding in twins. Am J Clin Nutr 1986; 43:723-31.
6. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Prog Endocrinol Metab 1981; 30:89-104.
7. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of two cases. J Clin Endo 1954; 14:193-204.
8. Sissons JGP, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK. The Complement Abnormalities of Lipodystrophy. New Engl J Med 1976; 294:461-5.
9. McLean RH, Hoefnagel D. Partial Lipodystrophy and Familial C3 Deficiency. Hum Hered 1980; 30:149-54.
10. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbances. Lancet 1946; 1:724-41.
11. Kobberling J, Willms B, Kattermann R, Creutzfeld W. Lipodystrophy of the extremities. A dominant inherited syndrome associated with lipotrophic diabetes. Humangenetik 1975; 29:111-20.
12. Reardon W, Temple IK, Mackinnon H, Leonard JV, Baraitser M. Partial Lipodystrophy - a further male case. Clin Genet 1990; 38:391-5.
13. Burn J, Baraitser M. Partial lipodystrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome). J Med Genet 1986; 23:128-30.
14. WHO study group. Diabetes mellitus. Technical report series No. 727. WHO, Geneva, 1985.
15. Frisancho AR. Triceps skinfold and upper arm muscle size norms for assessment of nutritional status. Am J Clin Nutr 1974; 27:1052-8.
16. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiology 137:959-65.
17. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type II diabetes mellitus. Diabetic Medicine 1993; 10:305-12.
18. Byrne CD, Wareham NJ, Brown DC, Clark PMS, Cox LJ, Day NE, Palmer CR, Wang TWM, Williams DRR, Hales CN. Hypertriglyceridaemia in patients with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 1994; 37:889-96.
19. Hosker JP, Mathiews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC. Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 1985; 28:412-19.
20. Bagdade JD. Basal insulin and obesity. Lancet 1968; ii.630-1.
21. Modan M, Halin H, Almog S, Lusky A, Eshkol A, Shefi M, Shirit A, Fuchs Z. Hyperinsulinaemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75:809-17.
22. Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. The polycystic ovary syndrome. Cambridge MA, Blackwell, 1992.
23. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma hdl-cholesterol, triglyceride and insulin concentrations. J Int Med 1992; 231:25-30.
24. Stout RW. Insulin and atherosclerosis. In Stout RW, ed. Diabetes and atherosclerosis. Dordrecht, Kluwer, 1992:165-202.
25. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
26. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet 1987; 2:821-4.
27. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1:785-9.
28. Krook A, Kumar S, Laing I, Boulton AJM, Wass JAH, O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 1994; 43:357-67.
29. Choi W-H, O'Rahilly S, Buse JB, Rees A, Morgan R, Flier JS, Moller DE. Molecular scanning of the insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 1991; 40:1712-18.
30. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995; 377:151-5.
31. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994; 79:1147-56.
32. Lane MD, Lin F-T, MacDougald OA, Vasseur-Cognet M. Control of adipocyte differentiation by CCAAT/enhancer binding proteinα (C/EBPα). Int J Obesity 1996; 20 Suppl. 3:S91-6.